TITLE

Low-Density Lipoprotein Cholesterol Reduction and Prevention of Cardiovascular Disease

AUTHOR(S)
Stein, Evan A.
PUB. DATE
April 2009
SOURCE
Mayo Clinic Proceedings;Apr2009, Vol. 84 Issue 4, p307
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses lipid-density lipoprotein cholesterol (LDL-C) reduction and prevention of cardiovascular disease (CVD). It states that evidence supports a strategy of early and aggressive lowering of LDL-C levels for the primary prevention of coronary artery disease. It also recalls how the treatment guidelines in decreasing CVD risk is formed.
ACCESSION #
37356599

 

Related Articles

  • The effect of chickpeas on human serum lipids and lipoproteins. Pittaway, J. K.; Ahuja, K. D. K.; Chronopoulos, A.; Cehun, M.; Robertson, I. K.; Nestel, P. J.; Ball, M. J. // Asia Pacific Journal of Clinical Nutrition;2004 Supplement, Vol. 13, pS70 

    Background- Consumption of pulses has been associated with reduction of hypercholesterolaemia and reduced risk of coronary heart disease (CHD). Chickpeas have been a staple part of Indian, Mediterranean and African diets for many thousands of years but are a relatively novel addition to Western...

  • Importance of blood cellular genomic profile in coronary heart disease. Baba, M. Iqbal; Kaul, Deepak; Grover, Anil // Journal of Biomedical Science;Jan2006, Vol. 13 Issue 1, p17 

    Since receptor/transcription factor family especially peroxisome proliferator-activated receptors PPARs (α,␣γ) and liver X receptor α (LXRα) have been recognized to play crucial role in both lipid metabolism and inflammation, the present study was addressed to explore the...

  • Low-Density Lipoprotein Size, Pravastatin Treatment, and Coronary Events. Campos, Hannia; Moye, Lemuel A.; Glasser, Stephen P.; Stampfer, Meir J.; Sacks, Frank M. // JAMA: Journal of the American Medical Association;9/29/2001, Vol. 286 Issue 12, p1468 

    Presents a study to examine whether low-density lipoprotein (LDL) size is an independent predictor of recurrent coronary events in patients with known coronary heart disease (CHD), as opposed to a marker for other lipid abnormalities. Context; Objective; Design and setting; Participants; Main...

  • Quality improvement initiatives required to reduce repeat lipid testing.  // Endocrine Today;Aug2013, Vol. 12 Issue 8, p1 

    The article reports on a study which found that one-third of patients with coronary heart disease who reached target low-density lipoprotein (LDL) levels underwent repeat lipid panels, suggesting that quality improvement initiatives are required to reduce repeat lipid testing.

  • Lipid and Lipoprotein Profiles in Youth With and Without Type 1 Diabetes. Guy, John; Ogden, Lorraine; Wadwa, R. Paul; Hamman, Richard F.; Mayer-Davis, Elizabeth J.; Liese, Angela D.; D'agostino Jr., Ralph; Marcovina, Santica; Dabelea, Dana // Diabetes Care;Mar2009, Vol. 32 Issue 3, p416 

    OBJECTIVE -- The purpose of this study was to compare the lipid profile and the prevalence of lipid abnormalities in youth with and without type 1 diabetes and explore the role of glycemic control on the hypothesized altered lipid profile in youth with type 1 diabetes. RESEARCH DESIGN AND...

  • Vascular viewpoint. Anand, Sonia S. // Vascular Medicine;2003, Vol. 8 Issue 4, p289 

    Shares views on the effect of statins on low density lipoprotein, cholesterol, ischaemic heart disease, and stroke. Determination whether how much statins can reduce serum concentrations of low density lipoprotein cholesterol according to drug, dose, and duration of treatment; Number of patients...

  • The Role of Small, Dense Low-Density-Lipoproteins in Non-Coronary Forms of Atherosclerosis. Rizzo, Manfredi; Berneis, Kaspar // Vascular Disease Prevention;Jul2006, Vol. 3 Issue 3, p269 

    Small, dense low density lipoproteins (LDL) are associated with increased risk for cardiovascular disease and seem to be an important predictor of cardiovascular events and progression of coronary artery disease. In addition, the predominance of small dense LDL has been accepted as an emerging...

  • Lipoprotein(a) and Its Position among Other Risk Factors of Atherosclerosis. Zlatohlávek, L.; Zídková, K.; Vrablík, M.; Haas, T.; Prusíková, M.; Svobodová, H.; Češka, R. // Physiological Research;2008, Vol. 57 Issue 5, p777 

    Lipoprotein(a) [Lp(a)] comprises of an LDL particle and apolipoprotein(a) [apo(a)] and its elevated levels are considered a risk factor for atherosclerosis. The aim of our study was to find out whether elevated Lp(a) levels are associated with increased risk of atherosclerosis in patients with...

  • Treatment of Cholesterol Abnormalities. Lockman, Andrew R.; Tribastone, Andrea D.; Knight, Karen V.; Franko, John P. // American Family Physician;3/15/2005, Vol. 71 Issue 6, p1137 

    Cardiovascular disease and its subset coronary heart disease are leading causes of morbidity and mortality in the United States and worldwide. In general, higher levels of low-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease, myocardial infarction,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics